UNSPSC 51294206: Paraxazone

This classification denotes an anxiolytic with the molecular formula C10H10N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2H6ON8WA7L, chemically known as 2,3-dihydro-3-oxo-4h-1,4-benzoxazine-4-acetamide. but generally known as paraxazone, which bears US NIH Compound Identifier 3047812. European Medicines Agency schedules Paraxazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09619MIG.

UNSPSC 51294206 Paraxazone, a Commodity code, covers pharmaceutical products that state and local governments procure for emergency medical response and community health initiatives. Recent solicitations show that this code captures procurement of naloxone (opioid reversal medication) and associated drug deactivation systems for county health departments and emergency services. Issuing bodies under this code include county health authorities and public health departments that support harm reduction, opioid response, and emergency medical preparedness programs. The scope of work involves sourcing finished pharmaceutical products and related medical equipment in volume, with vendors responsible for meeting delivery schedules, maintaining cold-chain or storage requirements where applicable, and complying with federal and state pharmaceutical licensing and handling standards.

Seminole County, Florida posted IFB 60459723LAS in June 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford; the bid deadline was July 26, 2023, with a two-year initial term and one-year renewal option. The procurement required vendors to submit unit costs electronically, carry specified insurance, maintain E-Verify compliance, and comply with federal regulations including the Clean Air Act and Federal Water Pollution Control Act due to potential FEMA funding. Recent activity is concentrated in Florida, though the source provides limited visibility into broader geographic spread or repeat-buyer patterns across other states and localities. State and local healthcare departments and emergency management agencies appear to be the primary issuing bodies, though the dataset shows limited recent volume to characterize market concentration or seasonal trends.